Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.
A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1).
Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis.
Natalizumab treatment reduces endothelial activity in MS patients.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Daughters of mothers with multiple sclerosis: their experiences of play.
[Neuromyelitis optica spectrum disorder: a case report].
Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review.
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.
MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.
A review of the sheep-multiple sclerosis connection.
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
[The use of modern neuroimaging methods in studies of mechanisms of development cognitive disturbances in patients with multiple sclerosis].
Vitamin d and multiple sclerosis.
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.
Development and assessment of a website presenting evidence-based information for people with multiple sclerosis: the IN-DEEP project.
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
Potentiation of High Voltage-Activated Calcium Channels by 4-Aminopyridine Depends upon Subunit Composition.
Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosis.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
A comparative study of CSF neurofilament light and heavy chain protein in MS.
Modulation of the Innate Immune Response by Human Neural Precursors Prevails Over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model Of Pelizaeus-Merzbacher Disease.
Pages
« first
‹ previous
…
172
173
174
175
176
177
178
179
180
…
next ›
last »